Korea's Leading Indie Beauty Brand d'Alba, Reaches New Heights Globally with 210% Overseas Sales Surge

2025-01-15 d'Alba HaiPress

SEOUL,South Korea,Jan. 14,2025 -- Premium vegan beauty brandd'Alba has achieved significant growth in its overseas sales,rising to approximately KRW 150 billion won (USD 100 million) in 2024 - which is a 210% growth compared to the previous year. With this growth,d'Alba's international market revenue now accounts for 45% of its total revenue.

Its global growth came from its flagship product,the White Truffle First Spray Serum,alongside Waterful Sunscreen and Double cream. d'Alba's consistent performance across diverse global markets including Japan,ASEAN countries,US,EU,and Russia highlights its strong customer base and successful penetration into the international beauty scene.


d'Alba had been generating most of its sales from the Korean market until 2023. The First Spray Serum initially gained traction in Korea as the "Flight Attendant Mist" getting widely known with its innovative formulation based on premium ingredients like White Truffles with the convenience of a spray. With this product,the brand gained its leading position in the domestic market with notable references in the major beauty channels - top 3 at Olive Young,1st rank in the Naver Shopping Beauty Category,and 1st rank in Coupang's Suncare/Essence/Ampoule Category.

Previously recognized primarily for its strong domestic performance,d'Alba has swiftly transitioned to the global stage. In 2024,d'Alba's overseas revenue climbed significantly to USD 110 mn from USD 35 mn in 2023. Now d'Alba's global sales accounts for 45% of total sales whereas it was about 22% in 2023.


An industry expert commented,"While many K-beauty brands' revenue rely on specific markets such as China,U.S,or Japan,d'Alba's evenly distributed growth across Europe,Japan,North America,and ASEAN is a rarity. This positions them uniquely in the competitive landscape."

Looking ahead,the brand is optimistic about the continued expansion,stating "These global markets are still at the early stage. We're receiving many inquiries from large retail platforms worldwide. Our focus on channel expansion and the new products such as beauty devices will drive further growth."

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map